The estimated Net Worth of Michael E Paolucci is at least $752 Tausend dollars as of 22 November 2021. Mr. Paolucci owns over 2,000 units of Orthofix Medical Inc stock worth over $472,253 and over the last 11 years he sold OFIX stock worth over $0. In addition, he makes $279,981 as Independent Director at Orthofix Medical Inc.
Michael has made over 1 trades of the Orthofix Medical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of OFIX stock worth $62,300 on 22 November 2021.
The largest trade he's ever made was buying 2,000 units of Orthofix Medical Inc stock on 22 November 2021 worth over $62,300. On average, Michael trades about 154 units every 0 days since 2014. As of 22 November 2021 he still owns at least 27,141 units of Orthofix Medical Inc stock.
You can see the complete history of Mr. Paolucci stock trades at the bottom of the page.
Michael E. Paolucci is Independent Director of the Company. He was named to the Board and appointed to the Compensation Committee in March 2016. A seasoned Human Resource (HR) executive, Mr. Paolucci has more than 20 years of global experience working directly with Boards of Directors and C-level executives to improve organizational capabilities and HR programs that result in sustained improvements in business performance. From July 2015 until January 2020, he served as Vice President and Chief Human Resources Officer for Halozyme Therapeutics Inc., a late stage oncology and biopharmaceutical company. From August 2014 to June 2015, Mr. Paolucci served as Executive Vice President and Chief Human Resource Officer for CareFusion. He also served as Executive Vice President of Human Resources at NuVasive from February 2014 to August 2014, and spent five years at Life Technologies from 2009 to February 2014. Previously, he was head of Human Resources for the services division of Hewlett Packard and served in several leadership roles with EDS, which was acquired by Hewlett Packard. Prior to HP/EDS, he was a partner with the HR consulting firm Towers Perrin. Mr. Paolucci is a graduate of Ohio State University.
As the Independent Director of Orthofix Medical Inc, the total compensation of Michael Paolucci at Orthofix Medical Inc is $279,981. There are 9 executives at Orthofix Medical Inc getting paid more, with Jon Serbousek having the highest compensation of $4,076,200.
Michael Paolucci is 60, he's been the Independent Director of Orthofix Medical Inc since 2016. There are 4 older and 12 younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth und Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: